Hong Kong Luxury Stock News

SEHK:3696
SEHK:3696Life Sciences

Insilico Medicine Advances AI Drug Discovery Model With New Partnerships

Insilico Medicine Cayman TopCo (SEHK:3696) has secured a partnership with Qilu Pharmaceutical focused on cardiometabolic disease drug candidates. The company received FDA IND clearance for a novel NLRP3 inhibitor, ISM8969, targeting Parkinson's Disease. Insilico launched its Science MMAI Gym to make its AI tools available to pharma R&D partners. A global co development agreement for ISM8969 was signed with Hygtia Therapeutics, expanding the candidate's reach. For investors tracking AI...
SEHK:1810
SEHK:1810Tech

Is Xiaomi (SEHK:1810) Pricing Look Attractive After Recent Share Price Weakness

Wondering whether Xiaomi’s current share price reflects its real worth, or if the market is mispricing the story you see playing out? Xiaomi closed at HK$35.06, with a 0.5% decline over the last 7 days, a 13.0% decline over the last month and year to date, and a 7.6% decline over the last year, while the 3 year return sits at 173.5% and the 5 year return at 29.1%. These moves have kept Xiaomi on many investors’ watchlists, as price swings often prompt a closer look at what is driving...
SEHK:66
SEHK:66Transportation

How MTR’s A$2 Billion Green Bond Launch Will Impact MTR (SEHK:66) Investors

In late January 2026, MTR Corporation Limited issued two senior unsecured green bonds, a 4.886% 2030 note and a 5.582% 2038 note, each worth A$1.00 billion with fixed coupons. By tapping the green bond market at scale, MTR is reinforcing its sustainable finance credentials while broadening its access to climate-focused capital. With recent share gains as a backdrop, we’ll assess how MTR’s large green bond issuance shapes its investment narrative and funding profile. We've found 13 US stocks...